Literature DB >> 6491285

Cobra venom factor: structural homology with the third component of human complement.

C W Vogel, C A Smith, H J Müller-Eberhard.   

Abstract

The functional analogy between cobra venom factor (CVF), the complement-activating protein in cobra venom, and C3b, the activated form of the third complement component, prompted us to conduct a comparative analysis of structural properties of the two proteins derived from two phylogenetically distant species. We subjected CVF and human C3 and its physiologic cleavage products, C3b and C3c, to a variety of biochemical analyses. We report here structural similarities of these proteins, which include similarities in amino acid composition, far and near UV circular dichroism spectra, secondary structure, band patterns and pI values from isoelectric focusing, immunochemical cross-reactivity, ultrastructural morphology, and amino-terminal amino acid sequences. Analysis of these data reveals that, structurally, CVF resembles C3c more than C3b. We conclude that CVF is not the product of a convergent evolution, but is, in all likelihood, derived from a common C3 ancestor protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491285

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection.

Authors:  Dean T Nardelli; Joseph P Cloute; K H Kevin Luk; Jose Torrealba; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

2.  Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.

Authors:  Bert J C Janssen; Lucio Gomes; Roman I Koning; Dmitri I Svergun; Abraham J Koster; David C Fritzinger; Carl-Wilhelm Vogel; Piet Gros
Journal:  EMBO J       Date:  2009-07-02       Impact factor: 11.598

3.  Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.

Authors:  A K Cheung; C J Parker; L Wilcox
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

4.  Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  M H Holguin; L R Fredrick; N J Bernshaw; L A Wilcox; C J Parker
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Proceedings of the British Pharmacological Society. 18th-20th December 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

Review 6.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

Review 7.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

8.  Molecular cloning and derived primary structure of cobra venom factor.

Authors:  D C Fritzinger; R Bredehorst; C W Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway.

Authors:  Rheba S Bonaparte; Pamela S Hair; Deepa Banthia; Dawn M Marshall; Kenji M Cunnion; Neel K Krishna
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

10.  The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.

Authors:  H Kitamura; M Tsuboi; K Nagaki
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.